Laboratorios Farmaceuticos Rovi S.a.

Laboratories Farmaceuticos Roui, S.a.

Elena Cebadera Miranda

Ibon Gutierro Aduriz

Maria Garcia Amo

Ivan Lopez-Belmonte Encina

Maria De Los Angeles Canales Mayordomo

Iván López-Belmonte Encina

Maria De Canales Mayordomo

Ibón Gutierro Aduriz

María GARCÍA Amo

Maria GARCÍA Amo

María De Los Angeles Canales Mayordomo

A sterile procedure for the filing of solids into pharmaceutical containers and the sealing thereof under sterile conditions is provided. Exemplary containers include syringes, vials, capsules, ampoules, single-dose devices or cartridges. The containers can be filled with powder, granules, nanoparticles or microparticles. After sealing, the containers are airtight. More specifically, the procedure minimizes adherence of those solids to the interior surfaces of the containers during the filling and sealing steps, thus ensuring airtightness of the seal and precision of the weight of the solid dispensed into the containers.

Procedure for the filling of solids in pharmaceutical containers and the sealing thereof under sterile conditions

A system for and method of gravimetric filling of a solid product in sterile conditions in a pharmaceutical container of small dimensions including syringes, vials, capsules, ampoules, single-dose devices, inhalers, bottles, carpules, well(s) of blister pack(s), sachets or bags with solid substances selected from the group formed by powder, lyophilizate, granules, pellets, nanoparticles or microparticles. More particularly, it relates to a process for the gravimetric filling of pharmaceutical containers with one or more sterile solid pharmaceutical substances or sterile excipients dosed and prepared in an aseptic environment.

Process and equipment assembly for aseptic gravimetric filling of solids into a container

Syringe backstop

The invention relates to a composition of glycosaminoglycans for the treatment of diabetic foot ulcer, it specifically relates to low molecular weight heparins (LMWHs) and very low molecular weight heparins (VLMWHs) in the treatment of chronic ulcers, particularly of diabetic foot ulcers, and more specifically in the manufacture of a medicinal product for the treatment of chronic ulcers, and particularly diabetic foot ulcers and pressure ulcers.

Pharmaceutical compositions with glycosaminoglycans and use thereof in the treatment of chronic ulcers

Growing community of inventors

Madrid, Spain

Elena Cebadera Miranda